Products from Israeli universities and hospitals earn $20b sales

Yissum CEO Yaacov Michlin: Each $1 million in exports creates 15 jobs.

Products that emerged from Israeli universities and hospitals have $20 billion in annual sales worldwide Yeda R&D Company Ltd., the technology transfer arm of the Weizmann Institute of Science, said CEO Amir Naiberg at the first annual conference of the Technology Transfer Companies in Israel in Tel Aviv yesterday.

Yissum Technology Transfer Company of the Hebrew University of Jerusalem president and CEO Yaacov Michlin added that this activity creates high-quality jobs. He estimated that each $1 million in exports creates 15 jobs.

Intel Israel president Mooly Eden said that, from his perspective as a company, industry sometimes beats academe. "It is necessary to build models in which academe can legally receive industry's know-how, because it is a shame for it to begin from zero." He added, "I regret that I lack the stamp of Israeli academe anywhere in an Intel chip, except that my developers in Israel are the product of Israeli academe. I want the inventions of Israeli academe to be embedded in the chip. This would better Intel Israel's position vis-a-vis Intel Corporation. Ireland cannot offer this because Irish academe is not of the same quality."

Published by Globes [online], Israel business news - www.globes-online.com - on June 13, 2012

© Copyright of Globes Publisher Itonut (1983) Ltd. 2012

5 Comments
View comments in rows
Update by email about comments talkback
POST
Comments
Your name
Please insert your name
Content
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

Thanks
You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
Twitter Facebook Linkedin RSS Newsletters גלובס